相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C. Schultz et al.
NATURE (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020
Elena A. Govorkova et al.
ANTIVIRAL RESEARCH (2022)
The effect of influenza virus on the metabolism of peripheral blood mononuclear cells with a metabolomics approach
Zeinab Karimi et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
Yucheng Zheng et al.
VIRUSES-BASEL (2022)
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
Kim M. Stegmann et al.
ISCIENCE (2022)
The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
Valentina Gaidano et al.
CANCERS (2021)
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication
Anna Luganini et al.
ANTIVIRAL RESEARCH (2021)
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety
Stefano Sainas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Arianna Calistri et al.
MICROORGANISMS (2021)
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses
Jun-Gyu Park et al.
JOURNAL OF VIROLOGY (2020)
The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain
Monika Loeffler et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Next-generation direct-acting influenza therapeutics
Mart Toots et al.
TRANSLATIONAL RESEARCH (2020)
Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection
Ana R. Coelho et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
Rui Xiong et al.
PROTEIN & CELL (2020)
Influenza and antiviral resistance: an overview
Temi Lampejo
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)
Current and future influenza vaccines
Seiya Yamayoshi et al.
NATURE MEDICINE (2019)
In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs
Lisa Marie Simon et al.
NUCLEIC ACIDS RESEARCH (2019)
Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool
Amesh Adalja et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
Mart Toots et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Dihydroorotate dehydrogenase inhibitors in anti-infective drug research
Donatella Boschi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Influenza virus-related critical illness: prevention, diagnosis, treatment
Eric J. Chow et al.
CRITICAL CARE (2019)
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
Jeong-Joong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors
Stefano Sainas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Influenza
Florian Krammer et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Frederick G. Hayden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin
Anna Luganini et al.
FRONTIERS IN MICROBIOLOGY (2018)
Treating Influenza Infection, From Now and Into the Future
Sophia Davidson
FRONTIERS IN IMMUNOLOGY (2018)
Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor
Godefridus J. Peters
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2018)
New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections
Simonides I. van de Wakker et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response
Nam Nam Cheung et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy
Ayse Okesli et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
The dihydroorotate dehydrogenases: Past and present
Renata A. G. Reis et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors
Clement Grandin et al.
ANTIVIRAL RESEARCH (2016)
Human Influenza Virus Infections
Christin Peteranderl et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance
Jennifer L. McKimm-Breschkin
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis
Qing-Yin Wang et al.
JOURNAL OF VIROLOGY (2011)
Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry
Anna Luganini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy
Joshua Munger et al.
NATURE BIOTECHNOLOGY (2008)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Dipyridamole, an underestimated vascular protective drug
W Schaper
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells
G Gribaudo et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts
G Gribaudo et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update
G Pizzorno et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells - ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine
JL Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
